Publications by authors named "Bryan Dechairo"

Claim this Profile
C
Correction: Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial.
Arun K Tiwari, Clement C Zai, C Anthony Altar, Julie-Anne Tanner, Paige E Davies, Bryan M Dechairo

Transl Psychiatry· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of combinatorial pharmacogenomic testing in depression: A Canadian patient- and rater-blinded, randomized, controlled trial.
Arun K Tiwari, Clement C Zai, C Anthony Altar, Julie-Anne Tanner, Paige E Davies, Bryan M Dechairo

Transl Psychiatry· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression.
Brent P Forester, Sagar V Parikh, Sara Weisenbach, Olusola Ajilore, Ipsit Vahia, Bryan Dechairo

Focus (Am Psychiatr Publ)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Outcomes Following Combinatorial Pharmacogenomic Testing for Elderly Psychiatric Patients.
Michael R Jablonski, Raymond Lorenz, James Li, Bryan M Dechairo

J Geriatr Psychiatry Neurol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial Pharmacogenomic Testing Improves Outcomes for Older Adults With Depression.
Brent P Forester, Sagar V Parikh, Sara Weisenbach, Olusola Ajilore, Ipsit Vahia, Bryan Dechairo

Am J Geriatr Psychiatry· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of combinatorial pharmacogenomic testing for depression from the Canadian public payer perspective.
Julie-Anne Tanner, Paige E Davies, Christopher C Overall, Daniel Grima, Julian Nam, Bryan M Dechairo

Pharmacogenomics· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical utility of combinatorial pharmacogenomic testing for patients with depression: a meta-analysis.
Lisa Brown, Oliver Vranjkovic, James Li, Kunbo Yu, Talal Al Habbab, Bryan Dechairo

Pharmacogenomics· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Burden of Depression and Associated Resource Use in Manitoba, Canada.
Julie-Anne Tanner, Jennifer Hensel, Paige E Davies, Lisa C Brown, Bryan M Dechairo

Can J Psychiatry· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian Medication Cost Savings Associated with Combinatorial Pharmacogenomic Guidance for Psychiatric Medications.
Julie-Anne Tanner, Lisa C Brown, Kunbo Yu, James Li, Bryan M Dechairo

Clinicoecon Outcomes Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adequate evidence to support improved outcomes in depression by primary care physicians compared to psychiatrists when using combinatorial pharmacogenomics.
Julie-Anne Tanner, Paige E Davies, Nicholas C Voudouris, Bryan M Dechairo, James L Kennedy

J Psychiatr Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetic analysis of opioid dependence treatment dose and dropout rate.
Richard C Crist, James Li, Glenn A Doyle, Alex Gilbert, Bryan M Dechairo

Am J Drug Alcohol Abuse· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to: Goldberg et al. and Severance et al. Letters to the Editor: The clinical significance of improving remission over standard of care - The reality of treatment resistant-based therapies.
John F Greden, Sagar V Parikh, Anthony J Rothschild, Michael E Thase, Boadie W Dunlop, Bryan Dechairo

J Psychiatr Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study.
John F Greden, Sagar V Parikh, Anthony J Rothschild, Michael E Thase, Boadie W Dunlop, Bryan Dechairo

J Psychiatr Res· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial pharmacogenomics and improved patient outcomes in depression: Treatment by primary care physicians or psychiatrists.
Julie-Anne Tanner, Paige E Davies, Nicholas C Voudouris, Anashe Shahmirian, Deanna Herbert, Bryan M Dechairo

J Psychiatr Res· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analytical validation of a psychiatric pharmacogenomic test.
Michael R Jablonski, Nina King, Yongbao Wang, Joel G Winner, Lucas R Watterson, Bryan M Dechairo

Per Med· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2018 American Society of Consultant Pharmacists Annual Meeting & Exhibition.
Mary Bridgeman, Donna Prete, Nicole Rolston, Daniel Abazia, Marc Sturgill, Bryan Dechairo

Consult Pharm· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Utility: Combinatorial Pharmacogenomics and Medication Cost Savings for Mental Health Care in a Primary Care Setting.
Lisa C Brown, Raymond A Lorenz, James Li, Bryan M Dechairo

Clin Ther· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation.
Joel G Winner, Joseph M Carhart, C Anthony Altar, Seth Goldfarb, Josiah D Allen, Bryan M Dechairo

Curr Med Res Opin· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial Versus Individual Gene Pharmacogenomic Testing in Mental Health: A Perspective on Context and Implications on Clinical Utility.
Joel G Winner, Bryan Dechairo

Yale J Biol Med· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Utility of Combinatorial Pharmacogenomics-Guided Antidepressant Therapy: Evidence from Three Clinical Studies.
C Anthony Altar, Joseph Carhart, Josiah D Allen, Daniel Hall-Flavin, Joel Winner, Bryan Dechairo

Mol Neuropsychiatry· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Testing Enhances Irritable Bowel Syndrome Medical Management: The IMMINENT Study.
Kelly Parsons, Julius Goepp, Bryan Dechairo, Elizabeth Fowler, Nathan Markward

Glob Adv Health Med· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder.
Joel G Winner, Joseph M Carhart, C Anthony Altar, Josiah D Allen, Bryan M Dechairo

Discov Med· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenomics and personalized medicine in clinical practice.
Vangelis G Manolopoulos, Bryan Dechairo, Alain Huriez, Alexander Kühn, Adrián Llerena

Pharmacogenomics· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analysis for genome-wide association study identifies multiple variants at the BIN1 locus associated with late-onset Alzheimer's disease.
Xiaolan Hu, Eve Pickering, Yingxue Cathy Liu, Stephanie Hall, Helene Fournier, Bryan Dechairo

PLoS One· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Learning from product labels and label changes: how to build pharmacogenomics into drug-development programs.
Linda C Surh, Michael A Pacanowski, Susanne B Haga, Stuart Hobbs, Lawrence J Lesko, Bryan Dechairo

Pharmacogenomics· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis